Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGND) Income from Non-Controlling Interests: 2014-2015

Historic Income from Non-Controlling Interests for Ligand Pharmaceuticals (LGND) over the last 2 years, with Dec 2015 value amounting to $2.4 million.

  • Ligand Pharmaceuticals' Income from Non-Controlling Interests fell 405.59% to -$1.5 million in Q2 2015 from the same period last year, while for Jun 2015 it was -$3.2 million, marking a year-over-year change of. This contributed to the annual value of $2.4 million for FY2015, which is 310.25% up from last year.
  • Latest data reveals that Ligand Pharmaceuticals reported Income from Non-Controlling Interests of $2.4 million as of FY2015, which was up 310.25% from -$1.1 million recorded in FY2014.
  • In the past 5 years, Ligand Pharmaceuticals' Income from Non-Controlling Interests ranged from a high of $2.4 million in FY2015 and a low of -$1.1 million during FY2014.
  • Over the past 2 years, Ligand Pharmaceuticals' median Income from Non-Controlling Interests value was $624,000 (recorded in 2014), while the average stood at $624,000.
  • Data for Ligand Pharmaceuticals' Income from Non-Controlling Interests shows a peak YoY soared of 310.25% (in 2015) over the last 5 years.
  • Over the past 2 years, Ligand Pharmaceuticals' Income from Non-Controlling Interests (Yearly) stood at -$1.1 million in 2014, then spiked by 310.25% to $2.4 million in 2015.